Antimicrobial resistance of Shigella isolates in Bangladesh, 1983-1990: increasing frequency of strains multiply resistant to ampicillin, trimethoprim-sulfamethoxazole, and nalidixic acid - PubMed (original) (raw)
Antimicrobial resistance of Shigella isolates in Bangladesh, 1983-1990: increasing frequency of strains multiply resistant to ampicillin, trimethoprim-sulfamethoxazole, and nalidixic acid
M L Bennish et al. Clin Infect Dis. 1992 May.
Abstract
The susceptibility to ampicillin and trimethoprim-sulfamethoxazole (TMP-SMZ) was determined for 15,824 isolates of Shigella obtained from patients attending a treatment center in Dhaka, Bangladesh, from 1983 through 1990 and for 520 isolates obtained during community surveys from 1988 through 1990. Susceptibility to nalidixic acid was determined for isolates obtained after 1985. In 1983 13% of isolates were resistant to ampicillin, 23.5% to TMP-SMZ, and 0.8% to both drugs. By 1990 51.2% of isolates obtained at the Diarrhea Treatment Centre were resistant to ampicillin, 47.7% to TMP-SMZ, and 40.5% to both drugs (for comparison with figures for 1983, P less than .001). Resistance to nalidixic acid increased from 0.8% in 1986 to 20.2% in 1990 (P less than .001). In 1990 71.5% of Shigella dysenteriae type 1 isolates were resistant to ampicillin, 68.5% to TMP-SMZ, 67.7% to both drugs, and 57.9% to nalidixic acid. The resistance pattern of isolates obtained during community surveillance was similar to that of Treatment Centre isolates. In Bangladesh ampicillin and TMP-SMZ are no longer useful for treatment of infection with any species of Shigella, and nalidixic acid is no longer useful for treatment of infections due to S. dysenteriae type 1.
Similar articles
- Monitoring of antibiotic resistance in shigellae isolated in The Netherlands 1984-1989.
Voogd CE, Schot CS, van Leeuwen WJ, van Klingeren B. Voogd CE, et al. Eur J Clin Microbiol Infect Dis. 1992 Feb;11(2):164-7. doi: 10.1007/BF01967070. Eur J Clin Microbiol Infect Dis. 1992. PMID: 1396730 - Surveillance of antimicrobial susceptibility patterns among Shigella species isolated in China during the 7-year period of 2005-2011.
Yang H, Chen G, Zhu Y, Liu Y, Cheng J, Hu L, Ye Y, Li J. Yang H, et al. Ann Lab Med. 2013 Mar;33(2):111-5. doi: 10.3343/alm.2013.33.2.111. Epub 2013 Feb 21. Ann Lab Med. 2013. PMID: 23482897 Free PMC article. - Response to antimicrobial therapy for shigellosis in Thailand.
Lolekha S, Vibulbandhitkit S, Poonyarit P. Lolekha S, et al. Rev Infect Dis. 1991 Mar-Apr;13 Suppl 4:S342-6. doi: 10.1093/clinids/13.supplement_4.s342. Rev Infect Dis. 1991. PMID: 2047660 Review. - Occurrence and susceptibility to antibiotics of Shigella species in stools of hospitalized children with bloody diarrhea in Pakistan.
Khalil K, Khan SR, Mazhar K, Kaijser B, Lindblom GB. Khalil K, et al. Am J Trop Med Hyg. 1998 Jun;58(6):800-3. doi: 10.4269/ajtmh.1998.58.800. Am J Trop Med Hyg. 1998. PMID: 9660467 - Antimicrobial-Resistant Shigella spp. in San Diego, California, USA, 2017-2020.
Gaufin T, Blumenthal J, Ramirez-Sanchez C, Mehta S, Pride DT, Fierer J, Jenks JD. Gaufin T, et al. Emerg Infect Dis. 2022 Jun;28(6):1110-1116. doi: 10.3201/eid2806.220131. Emerg Infect Dis. 2022. PMID: 35608550 Free PMC article. Review.
Cited by
- Characterizing Shigella species distribution and antimicrobial susceptibility to ciprofloxacin and nalidixic acid in Latin America between 2000-2015.
Sati HF, Bruinsma N, Galas M, Hsieh J, Sanhueza A, Ramon Pardo P, Espinal MA. Sati HF, et al. PLoS One. 2019 Aug 2;14(8):e0220445. doi: 10.1371/journal.pone.0220445. eCollection 2019. PLoS One. 2019. PMID: 31374081 Free PMC article. - Long-term comparison of antibiotic resistance in Vibrio cholerae O1 and Shigella species between urban and rural Bangladesh.
Klontz EH, Das SK, Ahmed D, Ahmed S, Chisti MJ, Malek MA, Faruque AS, Klontz KC. Klontz EH, et al. Clin Infect Dis. 2014 May;58(9):e133-6. doi: 10.1093/cid/ciu040. Epub 2014 Jan 22. Clin Infect Dis. 2014. PMID: 24457344 Free PMC article. - Intracellular activity of azithromycin against bacterial enteric pathogens.
Rakita RM, Jacques-Palaz K, Murray BE. Rakita RM, et al. Antimicrob Agents Chemother. 1994 Sep;38(9):1915-21. doi: 10.1128/AAC.38.9.1915. Antimicrob Agents Chemother. 1994. PMID: 7810998 Free PMC article. - Enhancement of fluoroquinolone activity by C-8 halogen and methoxy moieties: action against a gyrase resistance mutant of Mycobacterium smegmatis and a gyrase-topoisomerase IV double mutant of Staphylococcus aureus.
Lu T, Zhao X, Li X, Drlica-Wagner A, Wang JY, Domagala J, Drlica K. Lu T, et al. Antimicrob Agents Chemother. 2001 Oct;45(10):2703-9. doi: 10.1128/AAC.45.10.2703-2709.2001. Antimicrob Agents Chemother. 2001. PMID: 11557458 Free PMC article. - Medical practitioners' knowledge of dysentery treatment in Bangladesh.
Ronsmans C, Islam T, Bennish ML. Ronsmans C, et al. BMJ. 1996 Jul 27;313(7051):205-6. doi: 10.1136/bmj.313.7051.205. BMJ. 1996. PMID: 8696198 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical